LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Device Leads to Pain-Free Blood Tests

By LabMedica International staff writers
Posted on 29 Apr 2015
Print article
Image: A device the size of a pingpong ball can extract a small blood sample while held against the skin for two minutes (Photo courtesy of David Tenenbaum).
Image: A device the size of a pingpong ball can extract a small blood sample while held against the skin for two minutes (Photo courtesy of David Tenenbaum).
A device the size of a Ping-Pong ball can extract a small blood sample while held against the skin for two minutes which may make blood sampling less painful and more convenient.

A slight vacuum in the device enables a small sample of blood to flow into an attached sample tube, which can be mailed or handed to a laboratory and users report that the process is almost entirely painless.

Scientists at the University of Wisconsin-Madison (WI, USA) developed the device that can the device can extract about 0.15 mL of blood , which is enough to test cholesterol levels, infection biomarkers, cancer cells and blood glucose. The technology relies on the forces that govern the flow of tiny fluid streams.

The device is being perfected by Tasso Inc. (Madison, WI, USA). The company, whose name means "badger" in Italian, has applied for a patent on channels that create capillary action to move blood toward the sample tube. Ben Casavant, PhD, the vice president and co-founder of the company, said, “The technology relies on the forces that govern the flow of miniscule liquid streams. At these scales, surface tension dominates over gravity, and that keeps the blood in the channel no matter how you hold the device.”

Dr. Casavant added, “Although diabetics must test their blood sugar several times a day, they are not an initial market. We see our specialty as people who need to test semi-frequently or infrequently, to monitor cancer or chronic infectious diseases, for example. Instead of buying a machine or expensive equipment, we ship you this device, you put it on your arm for two minutes and send it back to the laboratory.” The device could help those who fear blood draws, and avoid time-consuming trips to laboratory for blood draws.

Related Links:

University of Wisconsin-Madison 
Tasso Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more